SHUKRAPHARPharmaceuticals
Shukra Pharmaceuticals Ltd — Cash Flow Statement
₹30.34
-3.42%
Shukra Pharmaceuticals Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 5.18 Cr | -6.96 Cr | -1.32 Cr | 6.44 Cr | — |
| Issuance Of Debt | 0.46 Cr | — | 0.64 Cr | 0.00 | 1.74 Cr |
| Issuance Of Capital Stock | 0.00 | 13.87 Cr | 4.63 Cr | 0.00 | — |
| Capital Expenditure | -2.74 Cr | -1.76 Cr | -4.49 Cr | -1.55 Cr | — |
| End Cash Position | 12.12 Cr | 9.98 Cr | 3.97 Cr | 0.29 Cr | — |
| Beginning Cash Position | 9.98 Cr | 3.97 Cr | 0.29 Cr | 0.50 Cr | — |
| Changes In Cash | 2.14 Cr | 6.01 Cr | 3.68 Cr | -0.21 Cr | — |
| Financing Cash Flow | -4.52 Cr | 12.40 Cr | 4.94 Cr | -6.68 Cr | — |
| Interest Paid Cff | -0.59 Cr | -0.28 Cr | -0.26 Cr | -0.28 Cr | — |
| Cash Dividends Paid | -4.38 Cr | -0.07 Cr | -0.07 Cr | — | — |
| Net Common Stock Issuance | 0.00 | 13.87 Cr | 4.63 Cr | 0.00 | — |
| Common Stock Issuance | 0.00 | 13.87 Cr | 4.63 Cr | 0.00 | — |
| Net Issuance Payments Of Debt | 0.46 Cr | -1.11 Cr | 0.64 Cr | -6.39 Cr | — |
| Net Long Term Debt Issuance | 0.46 Cr | -1.11 Cr | 0.64 Cr | -6.39 Cr | — |
| Long Term Debt Issuance | 0.46 Cr | — | 0.64 Cr | 0.00 | 1.74 Cr |
| Investing Cash Flow | -1.26 Cr | -1.20 Cr | -4.43 Cr | -1.53 Cr | — |
| Interest Received Cfi | 1.48 Cr | 0.56 Cr | 0.06 Cr | 0.03 Cr | — |
| Net Investment Purchase And Sale | 0.00 | 0.00 | 0.00 | -94000.00 | — |
| Net PPE Purchase And Sale | -2.74 Cr | -1.76 Cr | -4.49 Cr | -1.55 Cr | — |
| Purchase Of PPE | -2.74 Cr | -1.76 Cr | -4.49 Cr | -1.55 Cr | — |
| Operating Cash Flow | 7.92 Cr | -5.20 Cr | 3.17 Cr | 7.99 Cr | — |
| Taxes Refund Paid | -3.76 Cr | -0.62 Cr | -0.25 Cr | -0.44 Cr | — |
| Change In Working Capital | -3.78 Cr | -26.01 Cr | -2.62 Cr | 5.50 Cr | — |
| Change In Other Current Liabilities | 1.29 Cr | -2.70 Cr | 4.55 Cr | 1.80 Cr | — |
| Change In Other Current Assets | -15.16 Cr | -3.67 Cr | -11.28 Cr | 0.36 Cr | — |
| Change In Payable | 1.99 Cr | -26.15 Cr | 26.10 Cr | 3.26 Cr | — |
| Change In Inventory | -7.64 Cr | 0.84 Cr | 0.80 Cr | -2.27 Cr | — |
| Change In Receivables | 15.75 Cr | 5.67 Cr | -22.79 Cr | 2.35 Cr | — |
| Other Non Cash Items | -0.88 Cr | -0.52 Cr | -0.24 Cr | 0.25 Cr | — |
| Depreciation And Amortization | 3.00 Cr | 2.05 Cr | 1.84 Cr | 1.66 Cr | — |
| Depreciation | 3.00 Cr | 2.05 Cr | 1.84 Cr | 1.66 Cr | — |
| Pension And Employee Benefit Expense | 0.00 | 0.02 Cr | 94000.00 | 0.00 | — |
| Net Income From Continuing Operations | 13.34 Cr | 19.88 Cr | 4.44 Cr | 1.02 Cr | — |
| Repayment Of Debt | — | -1.11 Cr | — | -6.39 Cr | 0.00 |
| Other Cash Adjustment Outside Changein Cash | — | 1000.00 | — | 1000.00 | — |
| Long Term Debt Payments | — | -1.11 Cr | — | -6.39 Cr | 0.00 |
| Provisionand Write Offof Assets | — | -0.25 Cr | -0.44 Cr | 0.00 | — |
| Net Other Investing Changes | — | — | — | -1000.00 | 1000.00 |
| Sale Of PPE | — | — | — | 0.00 | 51000.00 |
| Interest Paid Cfo | — | — | — | -0.44 Cr | 0.00 |
| Common Stock Dividend Paid | — | — | — | — | 0.00 |
| Net Short Term Debt Issuance | — | — | — | — | 0.00 |
| Sale Of Investment | — | — | — | — | 0.00 |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Shukra Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.